{"id":"https://openalex.org/W7214044847","doi":"https://doi.org/10.64898/2026.09.16.26363059","title":"Targeting Pol\u03b8 Helicase with RP-3467: Preclinical Validation and Clinical Response in a g BRCA1 ovarian cancer patient with an acquired PARPi resistance mutation in TP53BP1","display_name":"Targeting Pol\u03b8 Helicase with RP-3467: Preclinical Validation and Clinical Response in a g BRCA1 ovarian cancer patient with an acquired PARPi resistance mutation in TP53BP1","publication_year":2026,"publication_date":"2026-09-22","ids":{"openalex":"https://openalex.org/W7214044847","doi":"https://doi.org/10.64898/2026.09.16.26363059","pmid":"https://pubmed.ncbi.nlm.nih.gov/42818163","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13622306"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.16.26363059","doi":"https://doi.org/10.64898/2026.09.16.26363059","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.16.26363059","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/22/2026.09.16.26363059.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/22/2026.09.16.26363059.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079802645","display_name":"Ezra Y. Rosen","orcid":"https://orcid.org/0000-0002-5289-1541","observed_orcids":["https://orcid.org/0000-0002-5289-1541"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ezra Y. Rosen","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063891743","display_name":"Marie\u2010Claude Mathieu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie-Claude Mathieu","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054965207","display_name":"Gino B. Ferraro","orcid":"https://orcid.org/0000-0002-1587-4259","observed_orcids":["https://orcid.org/0000-0002-1587-4259"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gino B. Ferraro","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055081132","display_name":"Philippe Mochirian","orcid":"https://orcid.org/0000-0002-2399-6061","observed_orcids":["https://orcid.org/0000-0002-2399-6061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Mochirian","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030723288","display_name":"Claude Godbout","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claude Godbout","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049930623","display_name":"Hugo Poirier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hugo Poirier","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025634177","display_name":"S. Fournier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara Fournier","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004547660","display_name":"Danielle Henry","orcid":"https://orcid.org/0000-0001-8851-7968","observed_orcids":["https://orcid.org/0000-0001-8851-7968"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danielle Henry","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152445889","display_name":"Hyeyeon Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hyeyeon Kim","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063354800","display_name":"R. Papp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Papp","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042914447","display_name":"Shou Yun Yin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shou Yun Yin","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067701795","display_name":"Marie-\u00c8ve Leclaire","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie-Eve Leclaire","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012642289","display_name":"Robert Houle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Houle","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024800524","display_name":"Parham Nejad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Parham Nejad","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061253538","display_name":"Joseph D. Schonhoft","orcid":"https://orcid.org/0000-0002-5860-5040","observed_orcids":["https://orcid.org/0000-0002-5860-5040"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph D. Schonhoft","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001256439","display_name":"Karl E. Zahn","orcid":"https://orcid.org/0000-0002-4865-2708","observed_orcids":["https://orcid.org/0000-0002-4865-2708"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karl E. Zahn","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152970492","display_name":"W. Cameron Black","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Cameron Black","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088204012","display_name":"Michel Gallant","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michel Gallant","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153010458","display_name":"Insil Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Insil Kim","raw_affiliation_strings":["Repare Therapeutics Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081904059","display_name":"Danielle Ulanet","orcid":"https://orcid.org/0009-0001-7754-9224","observed_orcids":["https://orcid.org/0009-0001-7754-9224"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danielle Ulanet","raw_affiliation_strings":["Repare Therapeutics Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152453845","display_name":"Paul Basciano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Basciano","raw_affiliation_strings":["Repare Therapeutics Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152980047","display_name":"Artur Veloso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Artur Veloso","raw_affiliation_strings":["Repare Therapeutics Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074475804","display_name":"Victoria M. Rimkunas","orcid":"https://orcid.org/0000-0003-4263-2009","observed_orcids":["https://orcid.org/0000-0003-4263-2009"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victoria Rimkunas","raw_affiliation_strings":["Repare Therapeutics Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068368047","display_name":"Timothy Anthony Yap","orcid":"https://orcid.org/0000-0002-2154-3309","observed_orcids":["https://orcid.org/0000-0002-2154-3309"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy A. Yap","raw_affiliation_strings":["Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050720271","display_name":"Robin Guo","orcid":"https://orcid.org/0000-0003-1722-1742","observed_orcids":["https://orcid.org/0000-0003-1722-1742"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Guo","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048997104","display_name":"Nicholas Mai","orcid":"https://orcid.org/0000-0002-1900-7945","observed_orcids":["https://orcid.org/0000-0002-1900-7945"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Mai","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048598383","display_name":"Maria T. Koehler","orcid":"https://orcid.org/0000-0002-4477-9621","observed_orcids":["https://orcid.org/0000-0002-4477-9621"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Koehler","raw_affiliation_strings":["Repare Therapeutics Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048516275","display_name":"Michael J. Zinda","orcid":"https://orcid.org/0009-0002-1394-2032","observed_orcids":["https://orcid.org/0009-0002-1394-2032"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Zinda","raw_affiliation_strings":["Repare Therapeutics Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056470194","display_name":"Anne Roulston","orcid":"https://orcid.org/0000-0003-4814-8242","observed_orcids":["https://orcid.org/0000-0003-4814-8242"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Roulston","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152959056","display_name":"Michal Zimmermann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michal Zimmermann","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152450616","display_name":"Stephen J. Morris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen J. Morris","raw_affiliation_strings":["Repare Therapeutics Inc., Saint Laurent, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Repare Therapeutics Inc., Saint Laurent, Quebec, Canada","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053124609","display_name":"Agnel J. Sfeir","orcid":"https://orcid.org/0000-0003-1633-8535","observed_orcids":["https://orcid.org/0000-0003-1633-8535"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Agnel Sfeir","raw_affiliation_strings":["Molecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":"https://orcid.org/0000-0003-1633-8535","affiliations":[{"raw_affiliation_string":"Molecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053124609"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-polymerase-theta","display_name":"DNA polymerase theta","score":0.9100000262260437},{"id":"https://openalex.org/keywords/parp-inhibitor-resistance","display_name":"PARP inhibitor resistance","score":0.8339999914169312},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9760000109672546},{"id":"https://openalex.org/keywords/microhomology-mediated-end-joining","display_name":"microhomology-mediated end joining","score":0.9800000190734863},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8989999890327454},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.8809999823570251},{"id":"https://openalex.org/keywords/rucaparib","display_name":"rucaparib","score":0.9660000205039978},{"id":"https://openalex.org/keywords/cip2a","display_name":"CIP2A","score":0.9240000247955322},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.607699990272522},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.597599983215332},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49790000915527344},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.47620001435279846},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4684000015258789},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.4620000123977661},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4147000014781952},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.39750000834465027},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.3862000107765198},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.36410000920295715},{"id":"https://openalex.org/C93304396","wikidata":"https://www.wikidata.org/wiki/Q14763008","display_name":"Mitosis","level":2,"score":0.362199991941452},{"id":"https://openalex.org/C161223559","wikidata":"https://www.wikidata.org/wiki/Q138864","display_name":"Helicase","level":4,"score":0.3310999870300293},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32839998602867126},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.32339999079704285},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.32199999690055847},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.3179999887943268},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.31529998779296875},{"id":"https://openalex.org/C2778480876","wikidata":"https://www.wikidata.org/wiki/Q21112674","display_name":"PARP1","level":5,"score":0.305400013923645},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3052999973297119},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.30390000343322754},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.28600001335144043},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.28349998593330383},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.2827000021934509},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.28209999203681946},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.27900001406669617},{"id":"https://openalex.org/C45080847","wikidata":"https://www.wikidata.org/wiki/Q1658004","display_name":"Micronucleus test","level":3,"score":0.25519999861717224},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.2535000145435333}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.64898/2026.09.16.26363059","doi":"https://doi.org/10.64898/2026.09.16.26363059","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.16.26363059","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/22/2026.09.16.26363059.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},{"id":"pmid:42818163","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42818163","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"medRxiv : the preprint server for health sciences","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13622306","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13622306/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"medRxiv","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.64898/2026.09.16.26363059","doi":"https://doi.org/10.64898/2026.09.16.26363059","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.16.26363059","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/22/2026.09.16.26363059.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3149714708","display_name":"Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors","funder_award_id":"5r01ca255074-03","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G491729079","display_name":"Investigating PolQ-mediated alternative NHEJ in breast cancer","funder_award_id":"R01CA229161","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7873194494","display_name":"MSK SPORE in Genomic Instability in Breast Cancer","funder_award_id":"P50CA247749","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000886102","display_name":"Investigating the role of Microhomology-Mediated End-Joining (MMEJ) in Mitosis and its impact on drug resistance","funder_award_id":"R01CA294696","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000907051","display_name":"The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer","funder_award_id":"P50CA281701","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306536","display_name":"V Foundation for Cancer Research","ror":"https://ror.org/00kbbk236"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214044847.pdf","grobid_xml":"https://content.openalex.org/works/W7214044847.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393071193","https://openalex.org/W4322772309","https://openalex.org/W4409691281","https://openalex.org/W4414059557","https://openalex.org/W4393096467","https://openalex.org/W3036860998","https://openalex.org/W4409689587","https://openalex.org/W4402746196","https://openalex.org/W3125948939","https://openalex.org/W7162630133"],"abstract_inverted_index":{"ABSTRACT":[0],"Homologous":[1],"recombination":[2],"(HR)":[3],"deficiency":[4],"underlies":[5],"a":[6,40,141,167,181],"range":[7],"of":[8,49,57,154],"cancers,":[9],"and":[10,28,76,100,109,134,149,191,214],"PARP":[11],"inhibitors":[12],"(PARPi)":[13],"targeting":[14,45],"this":[15],"vulnerability":[16],"have":[17],"demonstrated":[18],"clinical":[19,34,144,155,196],"efficacy":[20],"in":[21,81,127,140,218],"BRCA1/2":[22],"-mutant":[23,162],"tumors.":[24],"However,":[25],"resistance":[26,190,213],"mechanisms":[27],"tolerability":[29],"issues":[30],"limit":[31],"their":[32],"long-term":[33],"effectiveness.":[35],"Here,":[36],"we":[37,91,119],"characterize":[38],"RP-3467,":[39],"novel,":[41],"selective":[42],"small-molecule":[43],"inhibitor":[44],"the":[46,54,58,208],"ATPase":[47],"domain":[48],"DNA":[50,79,125],"polymerase":[51],"theta":[52],"(Pol\u03b8),":[53],"key":[55],"mediator":[56],"error-prone":[59],"microhomology-mediated":[60],"end":[61],"joining":[62],"(MMEJ)":[63],"pathway.":[64],"We":[65],"demonstrate":[66],"that":[67,93,121,204],"RP-3467":[68,94,122,137,172],"potently":[69],"suppresses":[70],"Pol\u03b8":[71,205],"enzymatic":[72],"activity,":[73],"abrogates":[74],"MMEJ,":[75],"disrupts":[77],"mitotic":[78,124],"repair":[80],"HR-deficient":[82],"(HRD)":[83],"models,":[84],"inducing":[85],"synthetic":[86],"lethality.":[87],"In":[88],"preclinical":[89],"studies,":[90],"show":[92],"synergizes":[95],"strongly":[96],"with":[97,177],"PARPi":[98,189,212],"(olaparib":[99],"rucaparib),":[101],"achieving":[102],"sustained":[103],"tumor":[104],"regression":[105],"across":[106],"multiple":[107],"xenograft":[108,111],"patient-derived":[110],"(PDX)":[112],"models":[113],"without":[114],"added":[115],"systemic":[116],"toxicity.":[117],"Mechanistically,":[118],"find":[120],"increases":[123],"damage":[126],"vivo,":[128],"as":[129],"evidenced":[130],"by":[131],"elevated":[132],"micronuclei":[133],"CIP2A":[135],"foci.":[136],"was":[138],"evaluated":[139],"phase":[142],"1":[143],"trial":[145],"(":[146],"NCT06560632":[147],")":[148],"has":[150,207],"shown":[151],"preliminary":[152],"signs":[153],"activity.":[156],"A":[157],"heavily":[158],"pretreated":[159],"germline":[160],"BRCA1":[161],"ovarian":[163],"cancer":[164],"patient":[165],"achieved":[166],"confirmed":[168],"partial":[169],"response":[170],"to":[171,187,210],"plus":[173],"olaparib":[174],"(RECIST":[175],"v1.1),":[176],"retrospective":[178],"profiling":[179],"revealing":[180],"TP53BP1":[182],"loss-of-function":[183],"mutation":[184],"previously":[185],"linked":[186],"both":[188],"POLQ":[192],"dependency.":[193],"Although":[194],"broader":[195],"validation":[197],"is":[198],"needed,":[199],"these":[200],"early":[201],"findings":[202],"suggest":[203],"inhibition":[206],"potential":[209],"address":[211],"offer":[215],"therapeutic":[216],"benefit":[217],"HRD":[219],"cancers.":[220]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-09-23T00:00:00"}